A lipopeptide facilitate induction of Mycobacterium leprae killing in host cells

PLoS Neglected Tropical Diseases

Volumn 5, Issue 11, 2011, Pages

  Maeda, Yumi ^a   Tamura, Toshiki ^a   Fukutomi, Yasuo ^a   Mukai, Tetsu ^a   Kai, Masanori ^a   Makino, Masahiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 12; LIPOPEPTIDE; PERFORIN; BACTERIAL ANTIGEN; GNLY PROTEIN, HUMAN; GRANZYME; T LYMPHOCYTE ANTIGEN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEPROSY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM LEPRAE; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; BIOSYNTHESIS; CELL PROLIFERATION; IMMUNOLOGY; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY; SECRETION;

ANTIGENS, BACTERIAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; GRANZYMES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LIPOPEPTIDES; MICROBIAL VIABILITY; MYCOBACTERIUM LEPRAE; PERFORIN;

EID: 82555173766     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001401     Document Type: Article

References (42)

1. World Health Organization (2010) Global leprosy situation. Weekly epidemiological record 35: 337-348.
2. Ridley DS, Jopling WH, (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255-273.
3. Kaplan G, Cohn ZA, (1986) The immunobiology of leprosy. Int Rev Exp Pathol 28: 45-78.
4. Maeda Y, Makino M, Crick DC, Mahapatra S, Srisungnam S, et al. (2002) Novel 33-kilodalton lipoprotein from Mycobacterium leprae. Infect Immun 70: 4106-4111.
5. Yamashita Y, Maeda Y, Takeshita F, Brennan PJ, Makino M, (2004) Role of the polypeptide region of a 33 kDa mycobacterial lipoprotein for efficient IL-12 production. Cell Immunol 229: 13-20.
6. Tschumi A, Nai C, Auchli Y, Hunziker P, Gehrig P, et al. (2009) Identification of apolipoprotein n-acyltransferase (LNT) in mycobacteria. J Biol Chem 284: 27146-27156.
7. Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV, (2006) Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol 177: 422-429.
8. Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, et al. (2003) Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 9: 525-532.
9. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, et al. (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14.
10. Inaba K, Inaba M, Naito M, Steinman RM, (1993) Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 178: 479-488.
11. Makino M, Maeda Y, Mukai T, Kaufmann SH, (2006) Impaired maturation and function of dendritic cells by mycobacteria through IL-1beta. Eur J Immunol 36: 1443-1452.
12. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
13. Stenger S, Modlin RL, (2002) Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 14: 452-457.
14. Gansert JL, Kiessler V, Engele M, Wittke F, Rollinghoff M, et al. (2003) Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 170: 3154-3161.
15. Kaufmann SH, (1999) Cell-mediated immunity: dealing a direct blow to pathogens. Curr Biol 9: R97-99.
16. Thoma-Uszynski S, Stenger S, Modlin RL, (2000) CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J Immunol 165: 5773-5779.
17. Makino M, Baba M, (1997) A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand J Immunol 45: 618-622.
18. Maeda Y, Mukai T, Spencer J, Makino M, (2005) Identification of an immunomodulating agent from Mycobacterium leprae. Infect Immun 73: 2744-2750.
19. Levy L, Ji B, (2006) The mouse foot-pad technique for cultivation of Mycobacterium leprae. Lepr Rev 77: 5-24.
20. McDermott-Lancaster RD, Ito T, Kohsaka K, Guelpa-Lauras CC, Grosset JH, (1987) Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy. Int J Lepr Other Mycobact Dis 55: 889-895.
21. Hashimoto K, Maeda Y, Kimura H, Suzuki K, Masuda A, et al. (2002) Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immun 70: 5167-5176.
22. Hendry C, Dionne K, Hedgepeth A, Carroll K, Parrish N, (2009) Evaluation of a rapid fluorescent staining method for detection of mycobacteria in clinical specimens. J Clin Microbiol 47: 1206-1208.
23. Truman RW, Krahenbuhl JL, (2001) Viable Mycobacterium leprae as a research reagent. Int J Lepr Other Mycobact Dis 69: 1-12.
24. Kishida Y, Yoshikawa H, Myoui A, (2007) Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res 13: 59-67.
25. Bastian M, Braun T, Bruns H, Rollinghoff M, Stenger S, (2008) Mycobacterial lipopeptides elicit CD4+ CTLs in Mycobacterium tuberculosis-infected humans. J Immunol 180: 3436-3446.
26. Murray RA, Siddiqui MR, Mendillo M, Krahenbuhl J, Kaplan G, (2007) Mycobacterium leprae inhibits dendritic cell activation and maturation. J Immunol 178: 338-344.
27. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, et al. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184: 747-752.
28. Yamauchi PS, Bleharski JR, Uyemura K, Kim J, Sieling PA, et al. (2000) A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. J Immunol 165: 1506-1512.
29. Sallusto F, Cella M, Danieli C, Lanzavecchia A, (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389-400.
30. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, et al. (2003) DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197: 121-127.
31. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, et al. (2003) Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197: 7-17.
32. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, et al. (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202: 96-105.
33. Pearce EL, Shen H, (2007) Generation of CD8 T cell memory is regulated by IL-12. J Immunol 179: 2074-2081.
34. Shibagaki N, Udey MC, (2002) Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol 168: 2393-2401.
35. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, et al. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736.
36. Stenger S, Modlin RL, (1999) T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 2: 89-93.
37. van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R, (2008) Cytotoxic human CD4(+) T cells. Curr Opin Immunol 20: 339-343.
38. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, et al. (2001) CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 167: 2734-2742.
39. Ochoa MT, Stenger S, Sieling PA, Thoma-Uszynski S, Sabet S, et al. (2001) T-cell release of granulysin contributes to host defense in leprosy. Nat Med 7: 174-179.
40. Dieli F, Troye-Blomberg M, Ivanyi J, Fournie JJ, Krensky AM, et al. (2001) Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 184: 1082-1085.
41. Heibein JA, Barry M, Motyka B, Bleackley RC, (1999) Granzyme B-induced loss of mitochondrial inner membrane potential (Delta Psi m) and cytochrome c release are caspase independent. J Immunol 163: 4683-4693.
42. Davis JE, Smyth MJ, Trapani JA, (2001) Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity. Eur J Immunol 31: 39-47.